UCBJF:OTCMKTS
UCB SA
235,94Â USD
0,00%
(0,00) 1Â D
13. okt., 10:35:17 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Endring | Endring (%) |
|---|
insights_autoGenererer viktig statistikk for UCBJF …
Markedsverdi
39,29Â mrd.
Snittvolum
142,00
Volum
180,00
52 u høy
345,39Â USD
52Â u lav
219,60Â USD
Beta
0,58
Utestående aksjer
194,51Â mill.
Antall ansatte
9k
Markedsverdi
39,29Â mrd.
Snittvolum
142,00
Volum
180,00
52 u høy
345,39Â USD
52Â u lav
219,60Â USD
Beta
0,58
Utestående aksjer
194,51Â mill.
Antall ansatte
9k
Nyhetssaker
Fra nettkilder og nyhetspartnere
ad-hoc-news.de
·
for 20 timer siden
UCB dedicates Georgia site. UCB stock sits 30.78 percent below its high
ad-hoc-news.de
·
for 23 timer siden
UCB launches Wear It Out program: UCB stock pre-market at EUR 198.60
ad-hoc-news.de
·
for 1 døgn siden
UCB presented Bimzelx data. UCB stock loses 1.06 percent.??
ad-hoc-news.de
·
for 2 døgn siden
UCB dedicated Georgia site. UCB stock sits below EUR 206.70
Profil
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Om UCB SA
Administrerende direktørJean-Christophe Tellier
Ansatte9k
Grunnlagt18. jan. 1928
Hovedkontor-
Sektor-
Nettsteducb.com